Navigation Links
AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
Date:5/4/2009

- Company Also Submits sNDA for NEXIUM Capsules for Risk Reduction of Low-Dose Aspirin-Associated Peptic Ulcer -

WILMINGTON, Del., May 4 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for a product combining low dose aspirin with esomeprazole magnesium for the risk reduction of low dose aspirin-associated gastric and/or duodenal ulcers in patients at risk.

AstraZeneca also submitted a supplemental new drug application (sNDA) for NEXIUM(R) (esomeprazole magnesium) for the risk reduction of low dose aspirin-associated gastric and/or duodenal ulcers. NEXIUM already is approved for the risk reduction in the occurrence of gastric ulcers associated with continuous non-steroidal anti-inflammatory drug (NSAID) therapy in patients at risk for developing gastric ulcers.(1)

Low-dose aspirin is the mainstay in the prevention of cardio- and cerebrovascular events such as heart attack and stroke.(2A,3A) However, even at low doses, aspirin is associated with a risk of peptic ulcers and gastrointestinal symptoms.(3B,3C) These gastrointestinal side effects can lead patients to discontinue their aspirin therapy.(3D,3E) Discontinuation due to GI problems is associated with a three-fold higher risk of major CV events,(4A) which can occur within just 1-2 weeks of discontinuation.(4B) Up to 1 in 3 patients on low-dose ASA may develop upper GI symptoms.(5A,6A)

AstraZeneca conducted two studies to evaluate the safety and efficacy of NEXIUM in reducing the risk of gastric and/or duodenal ulcers in patients who take low dose aspirin (75-325 mg continuously during the study, which is defined as at least 5 days per week). One study compared NEXIUM 40 mg or 20 mg with placebo, while the oth
'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. AstraZenecas Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints
2. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
3. AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia
4. AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA
5. AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimers Disease
6. AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
7. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
8. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
9. AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... and PARIS , May ... ), a leading developer and manufacturer of precision guided ... of coronary and peripheral vascular disease, today announced preliminary ... asodilator I ndependent S tenosis E ... clinical trial session at EuroPCR 2013. These prospective results ...
(Date:5/23/2013)... , 22. Mai 2013 ... eine Tochtergesellschaft von Daiichi Sankyo Co., ... am 22. Mai die Maßnahmen bekannt, ... ergriffen hat, um sich der Angelegenheiten ... ( http://www.daiichisankyo.com/media_investors/media_relations/press_releases/index.html ). Daiichi ...
(Date:5/22/2013)... HILLS, Calif. , May 22, 2013 ... developing a medical device that will help alleviate the ... APT,s targeted apheresis cartridge is expected to be the ... leading cause of maternal and fetal death. ... the United States . It is ...
Breaking Medicine Technology:Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2
(Date:5/23/2013)... A new report estimates that upgrading ... save $2.1 billion without reducing access or the quality ... Florida and other state Medicaid programs could make more ... on to curb wasteful pharmacy spending. , Learn ... MedicaidPharmacySavings.com . , “The easiest way for Florida to ...
(Date:5/23/2013)... Looking for tips on how to avoid a ... caring for your aging parent? Today the ... the results of a survey of 335 geriatric care managers ... Here are the top 5 tips identified by these aging ... respondents selecting each option): , 1.    Give each family member opportunity ...
(Date:5/23/2013)... York, New York (PRWEB) May 23, 2013 ... year’s recall of Rejuvenate and ABG II Modular-Neck Hip Stems ... LLP notes that new research has found a connection between ... soft tissue destruction. The study, which was published on ... looked at 12 hips in 11 patients who reported ...
(Date:5/23/2013)... that the daily clearance of neutrophils from the body ... bone marrow into the bloodstream, according to a report ... are leukocytes (white blood cells) that defend the body ... perform their function, these cells release toxic substances when ... these substances in the wrong place by damaged neutrophils ...
(Date:5/23/2013)... To kick off barbecue season, fire up the grill ... calories with simple tips from Retrofit weight loss . ... summer. , “The powerful heat of the grill can be ... are not mindful of your selections, it can be as ... Amy Margulies. , Margulies advises clients to choose healthy options ...
Breaking Medicine News(10 mins):Health News:PCMA: Upgrading Medicaid Drug Benefits Could Save Florida $2.1 Billion 2Health News:New Survey of Aging Experts Gives Top 5 Tips for Avoiding Family Feud when Caring for Aging Parents 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 3Health News:Discarded immune cells induce the relocation of stem cells 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 3
... March 22, 2012, New York, NYAs the second anniversary ... Fund report finds that 49 states and the District ... implementation, such as passing legislation, issuing regulations or other ... reforms in the law include new rules for insurers ...
... , WEDNESDAY, March 21 (HealthDay News) -- When used ... as acupuncture, acupressure and dietary changes may spell significant ... study suggests. The authors say that their study ... combining Western medicine with Eastern therapies among these patients, ...
... HealthDay Reporter , WEDNESDAY, March 21 (HealthDay News) -- Men ... tissue taken from both bald and hairier spots on men,s ... loss. The researchers note that drugs that inhibit the ... could one day be used to help men preserve their ...
... team of researchers led by A. K. Rajasekaran, PhD, Director ... that a key protein involved in cell function and regulation ... Their work is published online in the American Journal ... Cigarette smoke is well recognized as a cause of ...
... March 21, 2012: Anxiety, depression, stress and ... use in youth, according to a study from Carolyn ... from the University of Washington and Seattle University. ... grade who felt more emotional support from teachers reported ...
... March 20, 2012) Ching-Hon Pui, M.D., a renowned leader ... recipient of the 2012 Pediatric Oncology Award from the American ... contributions to better understanding the blood cancer,s biology and treatment ... Pui will receive the award in June at the ...
Cached Medicine News:Health News:Nearly all states have taken action on Affordable Care Act's Patients' Bill of Rights 2Health News:Nearly all states have taken action on Affordable Care Act's Patients' Bill of Rights 3Health News:Nearly all states have taken action on Affordable Care Act's Patients' Bill of Rights 4Health News:Alternative Medicine May Help Ease Chronic Sinusitis 2Health News:Alternative Medicine May Help Ease Chronic Sinusitis 3Health News:Research Spots Potential New Target in Fight Against Baldness 2Health News:Research Spots Potential New Target in Fight Against Baldness 3Health News:Nemours researchers uncover new evidence of cancer-causing agent present in gaseous phase of cigarette smoke 2Health News:Middle school teacher support lowers risk for early alcohol use 2Health News:ASCO honors Ching-Hon Pui, M.D., for work advancing childhood cancer research and treatment 2Health News:ASCO honors Ching-Hon Pui, M.D., for work advancing childhood cancer research and treatment 3
... are constructed of a patented ... polyvinyl acetal sponge. Each device ... to both surgeon and patient, ... firm enough to gently manipulate ...
... KeraCel Ophthalmic Products are constructed ... of lint-free MEROCEL polyvinyl acetal ... to be beneficial to both ... absorbent, and yet firm enough ...
... Ophthalmic Products provide the ... free products for unparalleled ... cleaning of fine microsurgical ... material is highly absorbent, ...
... Merocel Ophthalmic Products provide ... fiber free products for ... safe cleaning of fine ... Merocel material is highly ...
Medicine Products: